End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.6 CNY | +0.10% | -1.40% | -15.74% |
Jun. 03 | Weiguang Biological Products Gets Nod for Human Prothrombin Complex | MT |
May. 20 | Shenzhen Weiguang Biological Products Co., Ltd. Approves Dividend for the Year 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.74% | 927M | |
-1.62% | 90.85B | |
-1.05% | 39.02B | |
-11.20% | 33.46B | |
-20.75% | 14.51B | |
-6.35% | 13.22B | |
-11.42% | 11.65B | |
-47.67% | 10.57B | |
+6.44% | 9.23B | |
+102.03% | 7.71B |
- Stock Market
- Equities
- 002880 Stock
- News Shenzhen Weiguang Biological Products Co., Ltd.
- Weiguang Biological Products Gets Registration Certificate for Human Coagulation Factor VIII Drug